Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Foscarnet
2. Foscarnet Barium (2:3) Salt
3. Foscarnet Calcium (2:3) Salt
4. Foscarnet Disodium Salt
5. Foscarnet Magnesium (2:3) Salt
6. Foscarnet Manganese (2+) (2:3) Salt
7. Foscarnet Sodium Hexahydrate
8. Foscarnet Trilithium Salt
9. Foscarnet Tripotassium Salt
10. Foscarnet Trisodium Salt
11. Foscavir
12. Phosphonoformate
13. Phosphonoformic Acid
14. Trisodium Phosphonoformate
1. 63585-09-1
2. Foscavir
3. Trisodium Phosphonoformate
4. Triapten
5. Trisodium Carboxyphosphate
6. Foscarnet Sodique
7. Foscarneto Sodico
8. Foscarnetum Natricum
9. Foscarnet Trisodium
10. Phosphonoformate
11. Phosphonoformic Acid, Trisodium Salt
12. Foscarnetsodium
13. Ehb 776
14. Trisodium;phosphonatoformate
15. Sodium Phosphonatoformate
16. Foscarnet (sodium)
17. Foscavir (tn)
18. Foscarnet Sodium Anhydrous
19. Phosphinecarboxylic Acid, Dihydroxy-, Oxide, Trisodium Salt
20. A-29622
21. 8c5oq81lwt
22. Ehb-776
23. Foscarnet Sodium Hydrate
24. Chebi:141644
25. Nsc-313410
26. Nsc-758148
27. Ncgc00094941-01
28. Foscarnet Sodico
29. Dsstox_cid_3078
30. Dsstox_rid_76865
31. Dsstox_gsid_23078
32. Trisodium Dioxidophosphinecarboxylate Oxide
33. Foscarnet Sodico [spanish]
34. Foscarnet Sodique [french]
35. Foscarnetum Natricum [latin]
36. Chembl754
37. Trisodium Phosphonoformate;phosphonoformic Acid Trisodium Salt
38. Virudin
39. Gefin
40. Foscarnet Sodique [inn-french]
41. Foscarneto Sodico [inn-spanish]
42. Foscarnetum Natricum [inn-latin]
43. Drg-0017
44. Cas-63585-09-1
45. A 29622
46. Unii-8c5oq81lwt
47. Dihydroxyphosphinecarboxylic Acid Oxide Trisodium Salt
48. Phosphonoformic Acid Trisodium Salt
49. Trisodium Carboxyphosphate (anhydrous)
50. Trisodium Phosphonoformate (anhydrous)
51. Foscarnet Sodium [usan:usp:inn:ban]
52. Trisodium Dioxidophosphanecarboxylate Oxide
53. Foscarnet Sodium (usp/inn)
54. Foscarnet Sodium [mi]
55. Spectrum1502019
56. Foscarnet Sodium [inn]
57. Foscarnet Sodium Assay Standard
58. Dtxsid6023078
59. Hms502n17
60. Foscarnet Sodium [who-dd]
61. Hms1921d18
62. Hms2092n15
63. Hms3651j20
64. Bcp14044
65. Tox21_111364
66. Ccg-40026
67. S3076
68. Akos003599741
69. Akos015951387
70. Tox21_111364_1
71. Ac-2085
72. Ks-1418
73. Nsc 313410
74. Nsc 758148
75. Ncgc00094941-02
76. Ncgc00178317-03
77. Ac-19808
78. Db-054506
79. Ft-0626544
80. Sw220295-1
81. D00579
82. D78325
83. Q27225687
84. Phosphinecarboxylic Acid, 1,1-dihydroxy-, 1-oxide, Sodium Salt (1:3)
Molecular Weight | 191.95 g/mol |
---|---|
Molecular Formula | CNa3O5P |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 0 |
Exact Mass | 191.91764294 g/mol |
Monoisotopic Mass | 191.91764294 g/mol |
Topological Polar Surface Area | 103 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 103 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
1 of 4 | |
---|---|
Drug Name | Foscarnet sodium |
PubMed Health | Foscarnet (Injection) |
Drug Classes | Antiviral |
Drug Label | FOSCAVIR is the brand name for foscarnet sodium. The chemical name of foscarnet sodium is phosphonoformic acid, trisodium salt. Foscarnet sodium is a white, crystalline powder containing 6 equivalents of water of hydration with an empirical formula o... |
Active Ingredient | Foscarnet sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 2.4gm/100ml |
Market Status | Prescription |
Company | Hospira |
2 of 4 | |
---|---|
Drug Name | Foscavir |
Drug Label | FOSCAVIR is the brand name for foscarnet sodium. The chemical name of foscarnet sodium is phosphonoformic acid, trisodium salt. Foscarnet sodium is a white, crystalline powder containing 6 equivalents of water of hydration with an empirical formula o... |
Active Ingredient | Foscarnet sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 2.4gm/100ml |
Market Status | Prescription |
Company | Clinigen Hlthcare |
3 of 4 | |
---|---|
Drug Name | Foscarnet sodium |
PubMed Health | Foscarnet (Injection) |
Drug Classes | Antiviral |
Drug Label | FOSCAVIR is the brand name for foscarnet sodium. The chemical name of foscarnet sodium is phosphonoformic acid, trisodium salt. Foscarnet sodium is a white, crystalline powder containing 6 equivalents of water of hydration with an empirical formula o... |
Active Ingredient | Foscarnet sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 2.4gm/100ml |
Market Status | Prescription |
Company | Hospira |
4 of 4 | |
---|---|
Drug Name | Foscavir |
Drug Label | FOSCAVIR is the brand name for foscarnet sodium. The chemical name of foscarnet sodium is phosphonoformic acid, trisodium salt. Foscarnet sodium is a white, crystalline powder containing 6 equivalents of water of hydration with an empirical formula o... |
Active Ingredient | Foscarnet sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 2.4gm/100ml |
Market Status | Prescription |
Company | Clinigen Hlthcare |
Reverse Transcriptase Inhibitors
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSCARNET SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.4GM/100ML
Packaging :
Approval Date : 2024-03-01
Application Number : 216602
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSCARNET SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.4GM/100ML
Packaging :
Approval Date : 2023-06-05
Application Number : 213807
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSCAVIR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.4GM/100ML
Packaging :
Approval Date : 1991-09-27
Application Number : 20068
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Foscavir
Dosage Form : Foscarnet Sodium 6.000Mg 250Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle CHK EV 250 ml 24 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSCARNET SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.4GM/100ML
Packaging :
Approval Date : 2021-01-29
Application Number : 212483
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSCARNET SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.4GM/100ML
Packaging :
Approval Date : 2021-04-21
Application Number : 213001
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSCARNET SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.4GM/100ML
Packaging :
Approval Date : 2005-05-31
Application Number : 77174
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Canada
Brand Name : VOCARVI
Dosage Form : SOLUTION
Dosage Strength : 24MG/ML
Packaging :
Approval Date :
Application Number : 2505924
Regulatory Info :
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSCARNET SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.4GM/100ML
Packaging :
Approval Date : 2023-11-29
Application Number : 213987
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
40
PharmaCompass offers a list of Foscarnet Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Foscarnet Sodium manufacturer or Foscarnet Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Foscarnet Sodium manufacturer or Foscarnet Sodium supplier.
PharmaCompass also assists you with knowing the Foscarnet Sodium API Price utilized in the formulation of products. Foscarnet Sodium API Price is not always fixed or binding as the Foscarnet Sodium Price is obtained through a variety of data sources. The Foscarnet Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Foscarnet Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Foscarnet Sodium, including repackagers and relabelers. The FDA regulates Foscarnet Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Foscarnet Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Foscarnet Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Foscarnet Sodium supplier is an individual or a company that provides Foscarnet Sodium active pharmaceutical ingredient (API) or Foscarnet Sodium finished formulations upon request. The Foscarnet Sodium suppliers may include Foscarnet Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Foscarnet Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Foscarnet Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Foscarnet Sodium active pharmaceutical ingredient (API) in detail. Different forms of Foscarnet Sodium DMFs exist exist since differing nations have different regulations, such as Foscarnet Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Foscarnet Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Foscarnet Sodium USDMF includes data on Foscarnet Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Foscarnet Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Foscarnet Sodium suppliers with USDMF on PharmaCompass.
A Foscarnet Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Foscarnet Sodium Certificate of Suitability (COS). The purpose of a Foscarnet Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Foscarnet Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Foscarnet Sodium to their clients by showing that a Foscarnet Sodium CEP has been issued for it. The manufacturer submits a Foscarnet Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Foscarnet Sodium CEP holder for the record. Additionally, the data presented in the Foscarnet Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Foscarnet Sodium DMF.
A Foscarnet Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Foscarnet Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Foscarnet Sodium suppliers with CEP (COS) on PharmaCompass.
A Foscarnet Sodium written confirmation (Foscarnet Sodium WC) is an official document issued by a regulatory agency to a Foscarnet Sodium manufacturer, verifying that the manufacturing facility of a Foscarnet Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Foscarnet Sodium APIs or Foscarnet Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Foscarnet Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Foscarnet Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Foscarnet Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Foscarnet Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Foscarnet Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Foscarnet Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Foscarnet Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Foscarnet Sodium suppliers with NDC on PharmaCompass.
Foscarnet Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Foscarnet Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Foscarnet Sodium GMP manufacturer or Foscarnet Sodium GMP API supplier for your needs.
A Foscarnet Sodium CoA (Certificate of Analysis) is a formal document that attests to Foscarnet Sodium's compliance with Foscarnet Sodium specifications and serves as a tool for batch-level quality control.
Foscarnet Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Foscarnet Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Foscarnet Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Foscarnet Sodium EP), Foscarnet Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Foscarnet Sodium USP).